{"id":"clobazam-low-dose","safety":{"commonSideEffects":[{"rate":null,"effect":"Sedation"},{"rate":null,"effect":"Ataxia"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Behavioral changes"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Clobazam binds to GABA-A receptors on neurons, potentiating the effect of the inhibitory neurotransmitter GABA. This increases chloride ion influx and neuronal hyperpolarization, raising the seizure threshold and reducing abnormal electrical activity in the brain. The low-dose formulation is designed to optimize efficacy while minimizing sedation and dependence risk.","oneSentence":"Clobazam is a benzodiazepine that enhances inhibitory GABAergic neurotransmission in the central nervous system to reduce seizure activity.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:06:22.102Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Adjunctive treatment of seizures in epilepsy"},{"name":"Lennox-Gastaut syndrome"}]},"trialDetails":[{"nctId":"NCT00518713","phase":"PHASE3","title":"Clobazam in Patients With Lennox-Gastaut Syndrome","status":"COMPLETED","sponsor":"Lundbeck LLC","startDate":"2007-08","conditions":"Epilepsy, Epilepsy, Generalized, Seizures","enrollment":238},{"nctId":"NCT00162981","phase":"PHASE2","title":"Clobazam in Subjects With Lennox-Gastaut Syndrome","status":"COMPLETED","sponsor":"Lundbeck LLC","startDate":"2005-10","conditions":"Epilepsy, Epilepsy, Generalized, Seizures","enrollment":68}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Onfi™"],"phase":"phase_3","status":"active","brandName":"Clobazam Low Dose","genericName":"Clobazam Low Dose","companyName":"Lundbeck LLC","companyId":"lundbeck-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Clobazam is a benzodiazepine that enhances inhibitory GABAergic neurotransmission in the central nervous system to reduce seizure activity. Used for Adjunctive treatment of seizures in epilepsy, Lennox-Gastaut syndrome.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2012-12-14T00:00:00.000Z","mah":"LUNDBECK PHARMS LLC","brand_name_local":"ONFI","application_number":"NDA203993"}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}